About us
Spinodal is developing the first disposable robotic catheter for interventional cardiology. The catheter can deliver diagnostics and therapeutics to the myocardium with x10 accuracy and unparalleled stability compared to conventional catheters and provide safe and reproducible access to complex anatomies and hard-to-reach areas of the heart – a growing clinical need. Initially targeting cardiac electrophysiology, Spinodal provides a cost-effective and scalable solution for robotic mapping and ablation of the heart with improved clinical and economical benefits for millions of procedures every year.
Our Technology
Spinodal’s technology stems from meta-material science developed at the Technion – IIT. It includes a scalable fabrication method for multi-stable tubular microstructures (down to 100 µm in dimeter), which provides the basis for the catheter’s tip structure, an actuation method which is based on modular segmental DOFs (Degrees of Freedom) in extension, curve and twist of the tip, and a set of proximal mechanisms allowing Robotic microfluidic dosing for controlled tip motions. Blended together, these unique technological features comprise a workflow which retains all the advantages of conventional catheter workflow, essential to the cath-lab, but add disruptive robotic capabilities. These capabilities in turn give the physician complete freedom of motion in areas of the heart which are practically inaccessible to conventional catheters.
The Market
Spinodal is focusing on navigation and delivery of ablation devices within the heart as a first MVP with an excellent product-market fit. The technology also applies to a wide range of delivery tasks to the cardiovascular space which can be the basis for future products:
- The global cardiac ablation devices market is valued at $8B (2022) with a CAGR of 14%, the US portion accounting for over 40% of the market, Spinodal’s initial focus. Access devices account for nearly 20% of the global market.
- Additional relevant markets include the transcatheter valvular therapies market valued at $10B (2022) with a CAGR of 17.6% and the heart closure devices market valued at $3B (2022) with a CAGR of 15%.
The Team
Shai Elbaz (Ph.D), Co-Founder & CEO
Shai holds a B.Sc in Aerospace engineering (Summa Cum Laude, ranked 1st in class) and a Ph.D in Mechanical engineering (direct excellence track) from the Technion – IIT. Shai Gained over 15 years of experience in the Robotics & Autonomous Systems industry and has held senior engineering positions in the aerospace sector where he led vast R&D projects and activities. He is inventor of a morphing aircraft wing technology (Metafoil) and related patents which were licensed to the industry.
Nadav Zemah, Co-Founder & CTO
Nadav holds a B.Sc in Mechanical engineering from Ben Gurion University and an M.E. in Mechanical engineering from the Technion – IIT. Nadav is an accomplished mechanical engineer and designer with over 10 years of industrial experience in product management and R&D program management. Nadav acquired vast knowledge and expertise in production methods, including a variety of plastics fabrication processes and novel catheter fabrication technologies. Nadav has a proven track record in prototyping new concepts and adoptingthe right scientific framework to support their technological growth.
Prof. Amir Gat (Ph.D), Co-Founder & CSO
Prof. Amir Gat is a theoretical fluid dynamicist and an expert in the field of low-Reynolds-number fluid-structure-interaction. He obtained his B.Sc (2005, Summa Cum Laude) and Ph.D (2010, special track) from the Faculty of Aerospace Engineering, Technion – IIT. He then proceeded to a postdoc position at Caltech (2010-2012) and is with the faculty of Mechanical Engineering since October 2012.
Prof. Gat, has been advancing world-class science in the fields of Soft-Robotics and Metamaterials for over a decade with over 100 publications in leading scientific journals. He is pioneering metamaterial science that involves fluids and solids, leveraging their interaction to create underactuated smart structures. Such structures are highly applicable to the field of minimally invasive surgery as they enable precision distal control and manipulability at the tips of interventional tools, a major unmet need across the interventional framework.
Contact info
Shai Elbaz, CEO
+972-58-4440321 | shai@spinodal-medical.com
POB 1252, Nazareth, 1711102, Israel